Profile
Dr. Walker A. Long, MD, is Chief Medical Officer & VP-Drug Development at Biolex Therapeutics, Inc. He is on the Board of Directors at BioMarck Pharmaceuticals Ltd.
Dr. Long was previously employed as Vice President-Clinical Development by AtheroGenics, Inc., Senior Vice President-Project Operations by Cato Research Ltd, a Faculty Member by University of North Carolina at Chapel Hill, and a Principal by Wellcome Research Laboratories.
He received his undergraduate degree from the University of North Carolina at Chapel Hill and a doctorate degree from the University of North Carolina at Chapel Hill.
Walker A. Long active positions
| Companies | Position | Start |
|---|---|---|
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Director/Board Member | - |
Former positions of Walker A. Long
| Companies | Position | End |
|---|---|---|
Wellcome Research Laboratories | Corporate Officer/Principal | - |
The University of North Carolina at Asheville
The University of North Carolina at Asheville Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Corporate Officer/Principal | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | - |
Biolex Therapeutics, Inc.
Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Develops and produces drugs | Chief Tech/Sci/R&D Officer | - |
Training of Walker A. Long
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Biolex Therapeutics, Inc.
Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Develops and produces drugs | Distribution Services |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Health Technology |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Commercial Services |
Wellcome Research Laboratories | |
The University of North Carolina at Asheville
The University of North Carolina at Asheville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Walker A. Long
















